Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA²LEN)

• Main Authors: J. Bousquet, P. Van Cauwenberge, N. Aït Khaled, C. Bachert, C. E. Baena-Cagnani, J. Bouchard, C. Bunnag, G. W. Canonica, K. H. Carlsen, Y. Z. Chen, A. A. Cruz, A. Custovic, P. Demoly, R. Dubakiene, S. Durham, W. Fokkens, P. Howarth, J. Kemp, M. L. Kowalski, V. Kvedariene, B. Lipworth, R. Lockey, V. Lund, S. Mavale-Manuel, E. O. Meltzer, J. Mullol, R. Naclerio, K. Nekam, K. Ohta, N. Papadopoulos, G. Passalacqua, R. Pawankar, T. Popov, P. Potter, D. Price, G. Scadding, F. E.R. Simons, V. Spicak, E. Valovirta, D. Y. Wang, B. Yawn, O. Yusuf
• Other Authors: CHU Montpellier
• Format: Review
• Published: 2018
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/23313
• Institution: Mahidol University

The pharmacologic treatment of allergic rhinitis proposed by ARIA is an evidence-based and step-wise approach based on the classification of the symptoms. The ARIA workshop, held in December 1999, published a report in 2001 and new information has subsequently been published. The initial ARIA docume...